MedTrace Logo

QR-Based Virtual Tour and Childbirth Outcomes

NCT07496879 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-03-27

No results posted yet for this study

Summary

Childbirth is a unique experience that affects maternal health physiologically, emotionally, and socially, and represents a crucial step in the transition to motherhood. Primiparous women often experience fear related to childbirth due to uncertainty about the process, pain, or possible complications. This randomized controlled trial aims to evaluate the effect of a QR code-based virtual tour of the delivery room on primiparous women's fear of childbirth, childbirth readiness, vaginal birth rate, and postpartum breastfeeding self-efficacy. Participants will be provided access to three virtual videos via QR codes, allowing them to explore the delivery room, understand the admission process, and learn about postpartum care. The study will assess outcomes using validated scales for childbirth fear, prenatal readiness, birth-related self-efficacy, and postpartum breastfeeding. By familiarizing participants with the delivery environment, this intervention aims to reduce fear, improve confidence and preparedness, and encourage vaginal delivery. The findings are expected to inform strategies to enhance maternal experiences, support national initiatives such as the Normal Birth Action Plan, and contribute to safer, more satisfying birth and breastfeeding outcomes.

Conditions

  • Fear of Childbirth
  • Primiparous Women
  • Vaginal Birth Rate
  • Childbirth Readiness

Interventions

BEHAVIORAL

Virtual Delivery Room Tour via QR Codes

Three short videos via QR codes on admission, labor room, and postpartum care.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • AYLA KANBUR, PROF. DR. · Atatürk University - Faculty of Health Sciences, Department of Midwifery

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-03-31
Completion
2026-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07496879 on ClinicalTrials.gov